title: Amlodipine versus nadolol in patients with stable angina pectoris.
authors.affiliation: Veterans Administration Medical Center, Washington, DC 20422.
authors.forename: S
authors.initials: S
authors.lastname: Singh
authors.forename: J
authors.initials: J
authors.lastname: Doherty
authors.forename: V
authors.initials: V
authors.lastname: Udhoji
authors.forename: K
authors.initials: K
authors.lastname: Smith
authors.forename: J
authors.initials: J
authors.lastname: Gorwit
authors.forename: S
authors.initials: S
authors.lastname: Bekheit
authors.forename: S
authors.initials: S
authors.lastname: Mather
authors.forename: W
authors.initials: W
authors.lastname: Stein
authors.forename: J
authors.initials: J
authors.lastname: San Fellippo
authors.forename: P
authors.initials: P
authors.lastname: Hearan
mesh_terms: D000328:Adult; D000368:Aged; D017311:Amlodipine; D000787:Angina Pectoris / Q000188:drug therapy* / Q000503:physiopathology; D002121:Calcium Channel Blockers; D004334:Drug Administration Schedule; D005080:Exercise Test; D006801:Humans; D008875:Middle Aged; D009248:Nadolol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009543:Nifedipine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D002121:Calcium Channel Blockers; D017311:Amlodipine; D009248:Nadolol; D009543:Nifedipine